Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | 12-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,170 | -5,180 | -2,940 | -6,600 | -11,300 |
| Depreciation Amortization | 380 | 240 | 120 | 410 | 1,300 |
| Other Working Capital | 30 | -30 | -210 | -140 | 4,430 |
| Other Operating Activity | 10 | 0 | 10 | 20 | 1,700 |
| Operating Cash Flow | $-6,750 | $-4,970 | $-3,020 | $-6,310 | $-3,870 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -80 | -20 | -10 | -410 | -680 |
| Other Investing Activity | -6,780 | -9,050 | -160 | -290 | -1,080 |
| Investing Cash Flow | $-6,860 | $-9,070 | $-170 | $-700 | $-1,760 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 11,950 | 11,700 | 11,500 | 6,770 | -80 |
| Financing Cash Flow | $11,950 | $11,700 | $11,500 | $6,770 | $-80 |
| Exchange Rate Effect | 0 | 0 | -2 | -80 | -40 |
| Beginning Cash Position | 6,180 | 6,180 | 6,180 | 6,520 | 24,920 |
| End Cash Position | 4,530 | 3,840 | 14,480 | 6,180 | 19,150 |
| Net Cash Flow | $-1,650 | $-2,340 | $8,290 | $-330 | $-5,770 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,750 | -4,970 | -3,020 | -6,310 | -3,870 |
| Free Cash Flow | -6,750 | -4,970 | -3,020 | -6,310 | -3,870 |